Novel Molecular Targets for Systemic Lupus Erythematosus

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|3|3|223-228

ISSN： 1389-4501

Source： Current Drug Targets, Vol.3, Iss.3, 2002-06, pp. : 223-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Molecular Targets for Systemic Lupus Erythematosus and Other Immune-Complex and T-Cell Mediated Autoimmune Diseases - Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 331-332

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets of Misguided T Cells in Systemic Lupus Erythematosus

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 295-298

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Abnormalities in Systemic Lupus Erythematosus as Potential Drug Targets

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 305-311

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa   Perl Andras  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Belimumab: In Systemic Lupus Erythematosus

By Burness Celeste B.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2435-2444

Adis International

Access to resources Recommend Favorite